Based on the provided news updates, here is a summary of the current week's news sentiment for Sun Pharmaceutical Industries:

**Notable Events:**

1. Sun Pharmaceutical Industries has entered into an exclusive agreement with Philogen for commercializing anti-cancer immunotherapy.
2. There is no other notable event mentioned in the provided news updates.

**News Sentiment:**

The news tone is **Positive** for the stock. The agreement with Philogen for commercializing anti-cancer immunotherapy has had a positive impact on the stock, with all three related news updates showing a +3.06% impact. This suggests that the market has responded favorably to this development, indicating a positive sentiment towards the stock.

In contrast, there is no negative news update in the current week to offset this positive sentiment. Overall, the news tone is positive, indicating that the stock is likely to be supported by this development.